Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lactibiane Buccodental
- Development stage
- Unknown
- Lead developer
- PiLeJe
- Modality
- Synthetic Biology Platforms → Engineered Microbial Therapeutics → Microbiome Therapeutics, Fresh FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Frozen FMT → Fecal Microbiota Transplantation (FMT) → Microbiome Therapeutics, Genetically Modified Bacteria → Engineered Microbial Therapeutics → Microbiome Therapeutics, Microbial Metabolites → Microbiome-Derived Products → Microbiome Therapeutics, Microbial Proteins → Microbiome-Derived Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
- Administration
- Oral, Buccal
01
Overview
Lactibiane Buccodental is a probiotic-based dietary supplement developed by PiLeJe specifically for the maintenance of oral health. The formulation contains 1 billion CFU of the microbiotic strain *Lactobacillus paracasei* LA 802, which is registered with the French National Collection of Microorganism Cultures (CNCM). It is enriched with Vitamin C, which supports normal collagen formation for the health of teeth and gums, and Vitamin D3, which contributes to the maintenance of normal dentition. The product is delivered as chewable tablets intended for local action in the oral cavity and is recommended for adults and children over the age of six.
- Brand names
- Lactibiane Buccodental
- Other names
- lactobacillus paracasei LA 802 + vitamin C + vitamin D3
02
Targets
PHD1 (Prolyl hydroxylase domain-containing protein 1)VDR (Vitamin D receptor)
Beyond the preview
Go deeper on Lactibiane Buccodental.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lactibiane Buccodental.